Asian Pacific Journal of Cancer Prevention

Asian Pacific Journal of Cancer Prevention (아시아태평양암예방학회)
권호 표지
DOI QR코드

DOI QR Code

Lymph Node Ratio is an Independent Prognostic Factor in Node Positive Rectal Cancer Patients Treated with Preoperative Chemoradiotherapy Followed by Curative Resection

  • Zeng, Wei-Gen (Department of Colorectal Surgery, Cancer Hospital, Chinese Academy of Medical Sciences, Peking Union Medical College) ;
  • Zhou, Zhi-Xiang (Department of Colorectal Surgery, Cancer Hospital, Chinese Academy of Medical Sciences, Peking Union Medical College) ;
  • Wang, Zheng (Department of Colorectal Surgery, Cancer Hospital, Chinese Academy of Medical Sciences, Peking Union Medical College) ;
  • Liang, Jian-Wei (Department of Colorectal Surgery, Cancer Hospital, Chinese Academy of Medical Sciences, Peking Union Medical College) ;
  • Hou, Hui-Rong (The Overall Planning Office, Cancer Hospital, Chinese Academy of Medical Sciences, Peking Union Medical College) ;
  • Zhou, Hai-Tao (Department of Colorectal Surgery, Cancer Hospital, Chinese Academy of Medical Sciences, Peking Union Medical College) ;
  • Zhang, Xing-Mao (Department of Colorectal Surgery, Cancer Hospital, Chinese Academy of Medical Sciences, Peking Union Medical College) ;
  • Hu, Jun-Jie (Department of Colorectal Surgery, Cancer Hospital, Chinese Academy of Medical Sciences, Peking Union Medical College)
  • Published : 2014.07.15
Download PDF
⟨ Previous Next ⟩

Abstract

Background: The lymph node ratio (LNR) has been shown to be an important prognostic factor for colorectal cancer. However, studies focusing on the prognostic impact of LNR in rectal cancer patients who received neoadjuvant chemoradiotherapy (CRT) followed by curative resection have been limited. The aim of this study was to investigate LNR in rectal cancer patients who received neoadjuvant chemoradiotherapy (CRT) followed by curative resection. Materials and Methods: A total of 131 consecutive rectal cancer patients who underwent neoadjuvant CRT and total mesorectal excision were included in this study. Patients were divided into two groups according to the LNR (${\leq}0.2$ [n=86], >0.2 [n=45]) to evaluate the prognostic effect on overall survival (OS) and disease-free survival (DFS). Results: The median number of retrieved and metastatic lymph node (LN) was 14 (range 1-48) and 2 (range 1-10), respectively. The median LNR was 0.154 (range 0.04-1.0). In multivariate analysis, LNR was shown to be an independent prognostic factor for both overall survival (hazard ratio[HR]=3.778; 95% confidence interval [CI] 1.741-8.198; p=0.001) and disease-free survival (HR=3.637; 95%CI 1.838-7.195; p<0.001). Increased LNR was significantly associated with worse OS and DFS in patients with <12 harvested LNs, and as well as in those ${\geq}12$ harvested LNs (p<0.05). In addition, LNR had a prognostic impact on both OS and DFS in patients with N1 staging (p<0.001). Conclusions: LNR is an independent prognostic factor in ypN-positive rectal cancer patients, both in patients with <12 harvested LNs, and as well as in those ${\geq}12$ harvested LNs. LNR provides better prognostic value than pN staging. Therefore, it should be used as an additional prognostic indicator in ypN-positive rectal cancer patients.

Keywords

References

  1. Baxter NN, Virnig DJ, Rothenberger DA, et al (2005). Lymph node evaluation in colorectal cancer patients: a population-based study. J Natl Cancer Inst, 97, 219-25. https://doi.org/10.1093/jnci/dji020
  2. Chang GJ, Rodriguez-Bigas MA, Eng C, Skibber JM (2009). Lymph node status after neoadjuvant radiotherapy for rectal cancer is a biologic predictor of outcome. Cancer, 115, 5432-40. https://doi.org/10.1002/cncr.24622
  3. Doll D, Gertler R, Maak M, et al (2009). Reduced lymph node yield in rectal carcinoma specimen after neoadjuvant radiochemotherapy has no prognostic relevance. World J Surg, 33, 340-7. https://doi.org/10.1007/s00268-008-9838-8
  4. Gao C, Li JT, Fang L, Wen SW, Zhang L, Zhao HC (2013). Pre-operative predictive factors for intra-operative pathological lymph node metastasis in rectal cancers. Asian Pac J Cancer Prev, 14, 6293-9. https://doi.org/10.7314/APJCP.2013.14.11.6293
  5. Goldstein NS, Sanford W, Coffey M, Layfield LJ (1996). Lymph node recovery from colorectal resection specimens removed for adenocarcinoma. Trends over time and a recommendation for a minimum number of lymph nodes to be recovered. Am J Clin Pathol, 106, 209-16. https://doi.org/10.1093/ajcp/106.2.209
  6. Greene FL, Stewart AK, Norton HJ (2002). A new TNM staging strategy for node-positive (stage III) colon cancer: an analysis of 50, 042 patients. Ann Surg, 236, 416-21. https://doi.org/10.1097/00000658-200210000-00003
  7. Jin J, Li YX, Liu YP, et al (2006). A phase I study of concurrent radiotherapy and capecitabine as adjuvant treatment for operable rectal cancer. Int J Radiat Oncol Biol Phys, 64, 725-9. https://doi.org/10.1016/j.ijrobp.2005.08.017
  8. Kang J, Hur H, Min BS, Lee KY, Kim NK (2011). Prognostic impact of the lymph node ratio in rectal cancer patients who underwent preoperative chemoradiation. J Surg Oncol, 104, 53-8. https://doi.org/10.1002/jso.21913
  9. Kapiteijn E, Marijnen CA, Nagtegaal ID, et al (2001). Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer. N Engl J Med, 34, 638-46.
  10. Kim NK, Baik SH, Seong JS, et al (2006). Oncologic outcomes after neoadjuvant chemoradiation followed by curative resection with tumor-specific mesorectal excision for fixed locally advanced rectal cancer:Impact of postirradiated pathologic downstaging on local recurrence and survival. Ann Surg, 244, 1024-30. https://doi.org/10.1097/01.sla.0000225360.99257.73
  11. Kim YW, Kim NK, Min BS, et al (2009). The influence of the number of retrieved lymph nodes on staging and survival in patients with stage II and III rectal cancer undergoing tumor-specific mesorectal excision. Ann Surg, 249, 965-72. https://doi.org/10.1097/SLA.0b013e3181a6cc25
  12. Klos CL, Bordeianou LG, Sylla P, Chang Y, Berger DL (2011). The prognostic value of lymph node ratio after neoadjuvant chemoradiation and rectal cancer surgery. Dis Colon Rectum, 54, 171-5. https://doi.org/10.1007/DCR.0b013e3181fd677d
  13. La Torre M, Mazzuca F, Ferri M, et al (2013). The importance of lymph node retrieval and lymph node ratio following preoperative chemoradiation of rectal cancer. Colorectal Dis, 5, 382-8.
  14. Lee SD, Kim TH, Kim DY, et al (2012). Lymph node ratio is an independent prognostic factor in patients with rectal cancer treated with preoperative chemoradiotherapy and curative resection. Eur J Surg Oncol, 38, 478-83. https://doi.org/10.1016/j.ejso.2012.03.002
  15. Lee WC, Yusof MM, Lau FN, Phua VC (2013). Preoperative long course chemoirradiation in a developing country for rectal carcinoma: Kuala Lumpur hospital experience. Asian Pac J Cancer Prev, 14, 3941-4. https://doi.org/10.7314/APJCP.2013.14.6.3941
  16. Madbouly KM, Abbas KS, Hussein AM (2013). Metastatic lymph node ratio in stage III rectal carcinoma is a valuable prognostic factor even with less than 12 lymph nodes retrieved: a prospective study. Am J Surg, [Epub ahead of print].
  17. Moug SJ, Saldanha JD, McGregor JR, Balsitis M, Diament RH (2009). Positive lymph node retrieval ratio optimises patient staging in colorectal cancer. Br J Cancer, 100, 1530-3. https://doi.org/10.1038/sj.bjc.6605049
  18. Nadoshan JJ, Omranipour R, Beiki O, et al (2013). Prognostic value of lymph node ratios in node positive rectal cancer treated with preoperative chemoradiation. Asian Pac J Cancer Prev, 14, 3769-72. https://doi.org/10.7314/APJCP.2013.14.6.3769
  19. Peschaud F, Benoist S, Julie C, et al (2008). The ratio of metastatic to examined lymph nodes is a powerful independent prognostic factor in rectal cancer. Ann Surg, 248, 1067-73. https://doi.org/10.1097/SLA.0b013e31818842ec
  20. Rosenberg R, Friederichs J, Schuster T, et al (2008). Prognosis of patients with colorectal cancer is associated with lymph node ratio: a single-center analysis of 3, 026 patients over a 25-year time period. Ann Surg, 248, 968-78. https://doi.org/10.1097/SLA.0b013e318190eddc
  21. Rullier A, Laurent C, Capdepont M, et al (2008). Lymph nodes after preoperative chemoradiotherapy for rectal carcinoma:number, status, and impact on survival. Am J Surg Pathol, 32, 45-50. https://doi.org/10.1097/PAS.0b013e3180dc92ab
  22. Sauer R, Becker H, Hohenberger W, et al (2004). Preoperative versus postoperative chemoradiotherapy for rectal cancer. N Engl J Med, 351, 1731-40. https://doi.org/10.1056/NEJMoa040694
  23. Thorn CC, Woodcock NP, Scott N, et al (2004). What factors affect lymph node yield in surgery for rectal cancer? Colorectal Dis, 6, 356-61. https://doi.org/10.1111/j.1463-1318.2004.00670.x
  24. Wang H, Safar B, Wexner S, et al (2009). Lymph node harvest after proctectomy for invasive rectal adenocarcinoma following neoadjuvant therapy: does the same standard apply? Dis Colon Rectum, 52, 549-57. https://doi.org/10.1007/DCR.0b013e31819eb872

Cited by

  1. Can Induction Chemotherapy before Concurrent Chemoradiation Impact Circumferential Resection Margin Positivity and Survival in Low Rectal Cancers? vol.16, pp.7, 2015, https://doi.org/10.7314/APJCP.2015.16.7.2993
  2. Clinical parameters predicting pathologic complete response following neoadjuvant chemoradiotherapy for rectal cancer vol.34, pp.3, 2015, https://doi.org/10.1186/s40880-015-0033-7
  3. A Distal Resection Margin of ≤1 mm and Rectal Cancer Recurrence After Sphincter-Preserving Surgery vol.60, pp.11, 2017, https://doi.org/10.1097/DCR.0000000000000900
  4. Lymph node ratio is an independent prognostic factor for rectal cancer after neoadjuvant therapy: A meta-analysis vol.11, pp.3, 2018, https://doi.org/10.1111/jebm.12289